Đang chuẩn bị liên kết để tải về tài liệu:
Antitumor effects of cecropin B-LHRH’ on drug-resistant ovarian and endometrial cancer cells

Luteinizing hormone-releasing hormone receptor (LHRHr) represents a promising therapeutic target for treating sex hormone-dependent tumors. We coupled cecropin B, an antimicrobial peptide, to LHRH’, a form of LHRH modified at carboxyl-terminal residues 4–10, which binds to LHRHr without interfering with luteinizing hormone (LH) and follicle-stimulating hormone (FSH) secretion. |